Echo Therapeutics Initiates CE Mark Clinical Trial of its Symphony® CGM System (via PR Newswire)Download image PHILADELPHIA, June 5, 2013 /PRNewswire/ — Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it is initiating a multi-center clinical trial of its…